Soaring Anaphylaxis Treatment Market Size, Steered by Emerging Biologic Therapies and Enhanced Emergency Medical Services, Predicted to Reach $8.72 Billion in 2029

 

The anaphylaxis treatment market size has seen considerable growth in recent years, rising from $6.19 billion in 2024 to a projected $6.61 billion in 2025, at a compound annual growth rate (CAGR) of 6.9%. The growth during this period can be ascribed to increasing incidence of allergic reactions, wider recognition of anaphylaxis, increased availability of epinephrine auto-injectors, public awareness and education, and healthcare professional training.

Looking forward, the anaphylaxis treatment market size is forecasted to grow further to $8.72 billion in 2029, at a CAGR of 7.2%. This predicted growth can be attributed to innovation in biologic therapies, customized treatment approaches, global efforts on food safety, patient empowerment and advocacy, enhanced emergency medical services. Major trends in the forecast period include auto-injectors innovation, telemedicine for anaphylaxis management, improved allergen immunotherapy, biometric wearables for allergen detection, and collaborations in allergy research.

Get your free sample of the Global Anaphylaxis Treatment Market Report today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12105&type=smp

How is the Rising Prevalence of Food Allergies Influencing the Anaphylaxis Treatment Market Growth?
The surge in the prevalence of food allergies is propelling the anaphylaxis treatment market forward. The Centers for Disease Control and Prevention reported that in 2021, 31.8% of adults aged 18 and over had a seasonal allergy, 6.2% had a food allergy, and 7.3% had eczema. Also, the Food Standards Agency noted that a total of 296 valid case reports between October 2021 and August 27, 2023, had 72% of these reports attributed to food triggers and 97.7% occurred in children and young people aged 18 or younger. Due to these concerning figures, the rising prevalence of food allergies is undeniably driving the growth of the anaphylaxis treatment market.

Which Subsegments Define the Anaphylaxis Treatment Market Landscape?
Key subsegments of the anaphylaxis treatment market include -
1) By Treatment: Epinephrine, Antihistamines, Steroids, Beta-antagonists, Other Treatments
2) By Product: Tablets, Capsules, Other Products
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
4) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications

To learn more about the market dynamics, click the link below:
https://www.thebusinessresearchcompany.com/report/anaphylaxis-treatment-global-market-report

Which Key Companies Are Leading the Anaphylaxis Treatment Market?
Key market players include Merck & Co. Inc., Novartis International AG, GlaxoSmithKline plc, Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies, Sun Pharmaceutical Industries Ltd., Perrigo Co, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., ALK-Abelló A/S, Amphastar Pharmaceuticals Inc., Par Pharmaceutical Inc., Genentech Inc., Meridian Medical Technologies LLC, Aquestive Therapeutics Inc., Sandoz Inc., Adamis Pharmaceutical Corporation, and Impax Laboratories LLC.

What are the Emerging Trends in the Anaphylaxis Treatment Market?
Advancements in product development is a key trend observed in the anaphylaxis treatment market. For example, in April 2022, Aquestive Therapeutics Inc. received Fast Track designation for AQST-109 for the treatment of severe allergic responses, including anaphylaxis, from the Food and Drug Administration.

Which Region Leads the Anaphylaxis Treatment Market?
North America dominated the anaphylaxis treatment market in 2024, while Asia-Pacific is projected to be the fastest-growing region in the forecast period.

What Does the Anaphylaxis Treatment Market Report 2025 Offer?
Anaphylaxis treatment is crucial for handling life-threatening allergic reactions triggered by foods, insect stings, medications, and latex. Immediate administration of epinephrine reverses the allergic reaction and stabilizes the patient’s condition. Rapid medical treatment and comprehensive supportive care are integral to manage potential symptoms of anaphylaxis.

Have a look into the research report for more detailed insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12105

Contact Information:
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model